Company / Revenue per Share
Emergent BioSolutions Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$14.26
FY2025
5-year range
$14.26 / $34.57
FY2021-FY2025
Trend
-25.8%
vs FY2024
Sector context
#36 of 154
Health Care
What the data says
Emergent BioSolutions Inc.'s revenue per share of $14.26 is higher than 77% of companies in the Health Care sector (FY2025). Revenue per Share has declined for 4 consecutive years, from $34.57 in FY2021 to $14.26 in FY2025.
Based on SEC 10-K filings.
14.26 in FY2025 with a 5-year CAGR of -13.9%. Top quartile in the Health Care sector.
Declined from $20.10 to $14.26 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -13.2%
- 5-Year CAGR
- -13.9%
- 10-Year CAGR
- -
Sector benchmark
-5.5% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s revenue per share has declined for 4 consecutive years.
- In FY2025, revenue per share decreased 25.8% year-over-year.
- Ranks #36 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.26 | -25.8% |
| FY2024 | $19.22 | -4.4% |
| FY2023 | $20.10 | -7.7% |
| FY2022 | $21.78 | -37.0% |
| FY2021 | $34.57 | +14.9% |
| FY2020 | $30.09 | +40.6% |
| FY2019 | $21.39 | +116.2% |
| FY2018 | $9.89 | -28.4% |
| FY2017 | $13.82 | +11.4% |
| FY2016 | $12.40 | -10.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026